Log in to save to my catalogue

Mast cell activation in lungs during SARS-CoV-2 infection associated with lung pathology and severe...

Mast cell activation in lungs during SARS-CoV-2 infection associated with lung pathology and severe...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10541193

Mast cell activation in lungs during SARS-CoV-2 infection associated with lung pathology and severe COVID-19

About this item

Full title

Mast cell activation in lungs during SARS-CoV-2 infection associated with lung pathology and severe COVID-19

Publisher

United States: American Society for Clinical Investigation

Journal title

The Journal of clinical investigation, 2023-10, Vol.133 (19), p.1-12

Language

English

Formats

Publication information

Publisher

United States: American Society for Clinical Investigation

More information

Scope and Contents

Contents

Lung inflammation is a hallmark of Coronavirus disease 2019 (COVID-19) in patients who are severely ill, and the pathophysiology of disease is thought to be immune mediated. Mast cells (MCs) are polyfunctional immune cells present in the airways, where they respond to certain viruses and allergens and often promote inflammation. We observed widespr...

Alternative Titles

Full title

Mast cell activation in lungs during SARS-CoV-2 infection associated with lung pathology and severe COVID-19

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10541193

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10541193

Other Identifiers

ISSN

1558-8238,0021-9738

E-ISSN

1558-8238

DOI

10.1172/JCI149834

How to access this item